FDA issues guidance for clinical research and development on drugs containing cannabis and derived products
(Legal experts weigh in on what the FDA’s cannabis guidelines mean for the hemp industry.) Federal food and drug officials dropped draft guidance for clinical research related to developing cannabis and cannabis-derived drug products. The U.S. Food and Drug Administration’s seven-page draft guidance, titled “Cannabis and Cannabis-Derived Compounds: Quality... Read more
The Food and Drug Administration (FDA) published draft guidance on developing cannabis-based drugs on Tuesday. This comes weeks after the White House completed its review of the document, clearing its path for public release. FDA is still in the process of developing regulations that could allow for CBD to... Read more

Can These Pot Stocks to Watch Continue to Perform Well? Already in…

The post Numbers Are Up For These 2 Marijuana Stocks appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
The Justice Department is asking a federal court to force California marijuana regulators to disclose documents about cannabis businesses’ licenses and shipping manifests for reasons that remain unclear. A petition with the U.S. District Court for the Southern District of California on Monday says the Drug Enforcement Administration (DEA)... Read more
The Justice Department is asking a federal court to force California marijuana regulators to disclose documents about cannabis businesses’ licenses and shipping manifests for reasons that remain unclear. A petition with the U.S. District Court for the Southern District of California on Monday says the Drug Enforcement Administration (DEA)... Read more
Getting in fighting shape: 16 avenues cannabis executives are taking to manage through an economic downturn
(This is an abridged version of a story that appears in the July issue of Marijuana Business Magazine.) Recessions are a time for cost control, but they can also herald opportunity — especially if your industry proves as resilient as cannabis appears to be in the current downturn. Deciding... Read more
Organigram Reports Third Quarter Fiscal 2020 Results Net revenue of $18.0 million compared to $24.8 million in Q3 2019 Generated positive cash flow from operations of $8.5 million as a result of monetization and optimization of working capital and ended the quarter with cash and short-term investments of $44.8... Read more
Curaleaf Holdings Announces Closing of C$34.06 Million Private Placement of Subordinate Voting Shares WAKEFIELD, Mass., July 21, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading vertically integrated cannabis operator in the United States, announces today the closing of the private placement... Read more
A study by researchers at the University of California shows that cannabis may have the potential to treat the chronic pain associated with sickle cell disease. Results of the research, which was led by University of California at Irvine researcher Kalpna Gupta and Dr. Donald Abrams of U.C. San... Read more
Law enforcement data released by the California Department of Justice reveals that in 2019 the state recorded the lowest number of felony marijuana arrests since 1954, while showing that the racial disparity at play in such arrests continues to grow.  In the department’s latest “Crime in California” report, law... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )